These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 15136371)

  • 21. Outcomes and total costs of outpatient vs. inpatient peri-procedural anticoagulation management of mechanical prosthetic heart valve patients.
    Attaya H; Shah ND; Wysokinski WE; Van Houten HK; Heit JA; McBane RD
    Int J Cardiol; 2013 Oct; 168(6):5311-5. PubMed ID: 23998551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rivaroxaban versus Heparin Bridging to Warfarin Therapy: Impact on Hospital Length of Stay and Treatment Costs for Low-Risk Patients with Pulmonary Embolism.
    Weeda ER; Kohn CG; Peacock WF; Fermann GJ; Crivera C; Schein JR; Coleman CI
    Pharmacotherapy; 2016 Oct; 36(10):1109-1115. PubMed ID: 27548074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Economic and utilization outcomes associated with choice of treatment for venous thromboembolism in hospitalized patients.
    Knight KK; Wong J; Hauch O; Wygant G; Aguilar D; Ofman JJ
    Value Health; 2005; 8(3):191-200. PubMed ID: 15877591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hospitalizations and Other Health Care Resource Utilization Among Patients with Deep Vein Thrombosis Treated with Rivaroxaban Versus Low-molecular-weight Heparin and Warfarin in the Outpatient Setting.
    Deitelzweig S; Laliberté F; Crivera C; Germain G; Bookhart BK; Olson WH; Schein J; Lefebvre P
    Clin Ther; 2016 Aug; 38(8):1803-1816.e3. PubMed ID: 27491278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perioperative complications in patients on low-molecular-weight heparin bridging therapy.
    Breen DT; Chavalertsakul N; Paul E; Gruen RL; Serpell J
    ANZ J Surg; 2016 Mar; 86(3):167-72. PubMed ID: 23336820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost effectiveness of bemiparin sodium versus unfractionated heparin and oral anticoagulants in the acute and long-term treatment of deep vein thrombosis.
    Gómez-Outes A; Rocha E; Martínez-González J; Kakkar VV
    Pharmacoeconomics; 2006; 24(1):81-92. PubMed ID: 16445305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Venographic comparison of subcutaneous low-molecular weight heparin with oral anticoagulant therapy in the long-term treatment of deep venous thrombosis.
    Gonzalez-Fajardo JA; Arreba E; Castrodeza J; Perez JL; Fernandez L; Agundez I; Mateo AM; Carrera S; Gutiérrez V; Vaquero C
    J Vasc Surg; 1999 Aug; 30(2):283-92. PubMed ID: 10436448
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of a new standardized protocol for the perioperative management of chronically anticoagulated patients receiving implantable cardiac arrhythmia devices.
    Cano O; Muñoz B; Tejada D; Osca J; Sancho-Tello MJ; Olagüe J; Castro JE; Salvador A
    Heart Rhythm; 2012 Mar; 9(3):361-7. PubMed ID: 22001709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patients requiring interruption of long-term oral anticoagulant therapy: the use of fixed sub-therapeutic doses of low-molecular-weight heparin.
    Malato A; Saccullo G; Lo Coco L; Caramazza D; Abbene I; Pizzo G; Casuccio A; Siragusa S
    J Thromb Haemost; 2010 Jan; 8(1):107-13. PubMed ID: 19817996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation.
    Douketis JD; Spyropoulos AC; Kaatz S; Becker RC; Caprini JA; Dunn AS; Garcia DA; Jacobson A; Jaffer AK; Kong DF; Schulman S; Turpie AG; Hasselblad V; Ortel TL;
    N Engl J Med; 2015 Aug; 373(9):823-33. PubMed ID: 26095867
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-minimization analysis of low-molecular-weight heparin (dalteparin) compared to unfractionated heparin for inpatient treatment of cancer patients with deep venous thrombosis.
    Avritscher EB; Cantor SB; Shih YC; Escalante CP; Rivera E; Elting LS
    Support Care Cancer; 2004 Jul; 12(7):531-6. PubMed ID: 14986076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and Efficacy of Bridging With Low-Molecular-Weight Heparin During Temporary Interruptions of Warfarin: A Register-Based Cohort Study.
    Sjögren V; Grzymala-Lubanski B; Renlund H; Svensson PJ; Själander A
    Clin Appl Thromb Hemost; 2017 Nov; 23(8):961-966. PubMed ID: 28468510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of venous thromboembolism: adherence to guidelines and impact of physician knowledge, attitudes, and beliefs.
    Caprini JA; Tapson VF; Hyers TM; Waldo AL; Wittkowsky AK; Friedman R; Colgan KJ; Shillington AC;
    J Vasc Surg; 2005 Oct; 42(4):726-33. PubMed ID: 16242561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outpatient treatment of venous thromboembolism with low-molecular-weight heparin: an economic evaluation.
    Huse DM; Cummins G; Taylor DC; Russell MW
    Am J Manag Care; 2002 Jan; 8(1 Suppl):S10-6. PubMed ID: 11822346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen.
    Douketis JD; Johnson JA; Turpie AG
    Arch Intern Med; 2004 Jun; 164(12):1319-26. PubMed ID: 15226166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early postoperative bridging anticoagulation after mechanical heart valve replacement: a systematic review and meta-analysis.
    Passaglia LG; de Barros GM; de Sousa MR
    J Thromb Haemost; 2015 Sep; 13(9):1557-67. PubMed ID: 26178802
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perioperative Management of Vitamin K Antagonists and Direct Oral Anticoagulants: A Systematic Review and Meta-analysis.
    Shah S; Nayfeh T; Hasan B; Urtecho M; Firwana M; Saadi S; Abd-Rabu R; Nanaa A; Flynn DN; Rajjoub NS; Hazem W; Seisa MO; Hassett LC; Spyropoulos AC; Douketis JD; Murad MH
    Chest; 2023 May; 163(5):1245-1257. PubMed ID: 36462533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perioperative Heparin Bridging in Atrial Fibrillation Patients Requiring Temporary Interruption of Anticoagulation: Evidence from Meta-analysis.
    Ayoub K; Nairooz R; Almomani A; Marji M; Paydak H; Maskoun W
    J Stroke Cerebrovasc Dis; 2016 Sep; 25(9):2215-21. PubMed ID: 27289185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Half-dose enoxaparin vs. full-dose enoxaparin for postoperative bridging therapy in patients after cardiac surgery: which dose regimen should be preferred?
    Weiss A; Brose S; Ploetze K; Matschke K
    Clin Hemorheol Microcirc; 2013 Jan; 54(3):249-58. PubMed ID: 23648452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The economic impact of treating deep vein thrombosis with low-molecular-weight heparin: outcome of therapy and health economy aspects.
    Hull RD; Pineo GF; Raskob GE
    Haemostasis; 1998; 28 Suppl 3():8-16. PubMed ID: 10069757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.